ScreenerHero
DAPDanaher Corporation
XETRA · DE · Healthcare · Diagnostics & Research · danaher.com
187.20EUR-0.53%Mkt Cap: 142.58B $P/E: 38.47

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, L…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8

Key Statistics

Company
Market Cap142.58B $
Enterprise Value169.37B $
Revenue (TTM)27.29B $
Gross Profit15.79B $
Net Income (TTM)3.93B $
Revenue/Share38.56 USD
Last Price187.20 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees58.0K
CountryDE
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)38.47
P/E (Forward)—
PEG1.37
EV/EBITDA19.41
EV/Revenue6.21
P/S5.27
P/B2.90
EPS (TTM)4.85
EPS (Forward)—
52W Range
173.0093% of range188.20
52W High188.20 EUR
52W Low173.00 EUR
Profitability
Gross Margin59.11%
Oper. Margin19.78%
EBITDA Margin31.97%
Profit Margin14.71%
ROE6.88%
ROA4.33%
Growth
Revenue Growth5.50%
Earnings Growth59.70%
Cash Flow & Leverage
Operating CF6.97B $
CapEx (TTM)1.26B $
FCF Margin17.23%
FCF Yield3.30%
Net Debt25.55B $
Net Debt/EBITDA2.93
Balance Sheet
Debt/Equity0.37
Current Ratio1.65
Quick Ratio1.15
Book Value/Sh64.80 EUR
Cash/Share6.185 EUR
Dividends
Fwd Div Rate1.390 EUR
Trail. Div Rate1.440 EUR
Div. Yield0.77%
5Y Avg Yield0.44%
Payout Ratio25.67%
Ex-Div DateJun 26, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.702.99M
Float625.83M
Insiders10.96%
Institutions84.50%
Technical
SMA 50168.98 (+10.8%)
SMA 200174.19 (+7.5%)
Beta0.80
S&P 52W Chg18.16%
Avg Vol (30d)619
Avg Vol (10d)388
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—